Illustrative $3.5 million injectables med spa: a membership PE offer

This illustrative composite is not a client transaction. A $3.5 million injectables-led practice with forty percent membership revenue receives a hypothetical $2.7 million offer. Normalizing earnings and separating cash, equity, earnout, obligations, and reserves shows why a recurring-revenue story and an attractive headline do not establish the seller’s actual cash outcome.

Which assumptions define this membership practice?

Assume the practice earns $3.5 million annually, including $1.4 million attributed to membership arrangements under the stated reporting model. The forty-percent share is earned revenue, not simply cash collected or active enrollment. The example assumes healthcare counsel can support the actual ownership and clinical structure; it supplies no universal legal conclusion.

The seller is attracted to a platform proposal but wants to understand the tradeoff between liquidity and continuing exposure. The analysis therefore keeps historical financial adjustments, prepaid-service obligations, purchase consideration, employment, and equity investment separate rather than combining them into one recurring-revenue valuation claim.

How are the reported earnings normalized?

Assume reported net income is $415,000 after $45,000 interest, $65,000 depreciation, and $20,000 amortization. Reported EBITDA is $545,000. For this teaching case, documented nonrecurring legal costs add $35,000 and personal expenses add $18,000.

Now deduct $62,000 additional clinical replacement compensation, $28,000 administrative support, and a $40,000 correction for revenue recognized before the corresponding earning event under the model. Normalized EBITDA is $545,000 + $35,000 + $18,000 − $62,000 − $28,000 − $40,000 = $468,000.

A real accountant would verify the basis and records. The adjustments are assumptions, not a claim that every similarly named expense is accepted by buyers or lenders.

What makes the membership revenue worth investigating?

Request member cohorts, contract versions, opening accounts, joins, cancellations, pauses, failed collections, redemptions, refunds, and ending balances. Test whether retained members use services at a supportable contribution margin and whether the providers have capacity to honor promised benefits.

Assume the ledger contains $280,000 face value of unused credits. That balance is not automatically the cost of fulfillment or the negotiated closing adjustment. The parties need an agreed method that considers patient rights, accounting, service economics, and responsibility for the related cash and work.

The May 2026 AmSpa M&A commentary identifies recurring revenue as a market theme in its discussion of 2025. It does not establish an automatic premium for this hypothetical program. The evidence of profitable retention and clear obligations matters more than labeling collections recurring.

How is the teaching valuation range developed?

Apply assumed price factors of 5.2 and 6.1 to normalized EBITDA solely to demonstrate sensitivity. The resulting planning range is $2,433,600 to $2,854,800. These are invented factors, not public transaction observations, current market quotes, or an appraisal.

Assume the negotiated headline is $2.7 million. The price needs to be evaluated with the buyer’s funding, integration plan, professional continuity, provider retention, and payment structure. A factor applied to the uncorrected $545,000 would describe a different earnings case and exaggerate this illustration’s base.

Keep projected platform savings separate. If the buyer expects better purchasing, marketing, or administration, those benefits require its own cost and execution analysis. The seller’s historical accounts should not be rewritten as though unimplemented synergies already exist, and the same prospective benefit should not be counted twice.

What does the proposed consideration contain?

Assume seventy percent of the $2.7 million price is closing cash: $1.89 million. Twenty percent, $540,000, is assigned as rollover equity, and ten percent, up to $270,000, is an earnout. Together those components reconcile to the headline, but they have different legal and economic characteristics.

The rollover percentage describes the portion of this seller’s consideration retained as an investment. It does not mean the seller owns twenty percent of the entire acquiring platform. The actual class, capitalization, rights, priorities, and fully diluted ownership need to be established from the investment documents.

Federal resale provisions such as SEC Rule 144 contain conditions for certain securities transactions. Counsel should assess the applicable rules and contractual restrictions. Neither an entry valuation nor a hoped-for future platform sale makes retained equity equivalent to immediate cash.

How much cash is available at closing?

Start with $1.89 million cash consideration. Deduct $265,000 debt, $110,000 expenses, $75,000 escrow, and a $35,000 agreed closing adjustment. Cash before taxes is $1,405,000. The $35,000 is a hypothetical negotiated cutoff adjustment, not the $280,000 credit balance or the $40,000 historical recognition correction.

Assume a $315,000 planning tax reserve, leaving $1.09 million immediate unreserved cash. No tax rate is inferred. The IRS business-sale guidance explains why asset allocation, basis, entity structure, liabilities, and payment form affect the real result. The CPA must model actual facts.

Keep the $540,000 equity, potential $270,000 earnout, and $75,000 escrow separate from this cash. They represent different future exposures and cannot all be presented as guaranteed spendable proceeds. The seller’s salary for future clinical work also belongs outside the purchase-consideration calculation.

Which earnout and operating terms need scrutiny?

Define the earnout metric, period, accounting, permitted charges, reporting, review, and dispute process. If it depends on memberships or EBITDA, identify how pricing, program migration, staffing, marketing, allocations, refunds, and service availability affect the calculation after the buyer takes control.

Match the seller’s role with those decisions. A clinician continuing to treat patients may not control platform spending or a membership redesign. Verbal confidence that the target will be achieved is weaker than clear terms and verifiable records. Model partial or no payment rather than relying only on the maximum.

For privacy, the HIPAA definitions in 45 CFR 160.103 provide a classification starting point. Have counsel approve the appropriate diligence and post-close data arrangements. A retention analysis needs usable evidence, but does not justify unrestricted access to every identifiable treatment record.

What should a credible transition establish?

Agree on the qualified provider and leadership plan, member communications, contracts, payroll, purchasing, devices, records, and system access. Identify who honors existing benefits and handles cancellations or refunds. A program that appears attractive in a sales memorandum can create operational friction if its promises are unclear at handover.

Define the seller’s continuing duties, compensation, hours, professional role, and end date. Keep equity rights and employment rights distinct, and review what happens if employment ends. The business plan should not require the seller to remain indefinitely available to protect an uncertain earnout.

Preserve monthly baseline reports and compare actual results with the normalized model. Explain changes in definitions, timing, staffing, and program terms. That discipline helps both the new operator and seller distinguish an ordinary business development from a calculation dispute about contingent consideration.

What should the owner learn from this offer?

Recurring revenue can be valuable evidence when it is retained, profitable, and supported by clear obligations. It does not remove the need to normalize earnings or analyze investment and payment risk. The $2.7 million headline and $1.09 million immediate cash answer different questions.

Use the valuation hub, seller hub, buyer roadmap, and operations guide. The membership and deferred-revenue guide explains obligations, while the offer-to-proceeds bridge separates payment categories.

Apply the Four-Number Med Spa Valuation Screen with verified records. An actual offer needs its own market evidence, legal structure, accounting, and tax work; the composite supplies a method for asking better questions, not a price or outcome to expect.

Educational analysis prepared with AI-assisted research for The Med Spa Broker. “Last reviewed” records the source and editorial check date; it does not imply review by an attorney, clinician, or independent appraiser. Read our editorial standards.